References
1. Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk B, Chirlaque M et al. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. European Journal of Cancer. 2017;77:140-152. doi: 10.1016/j.ejca.2017.02.023
2. Mazzaferri E, Kloos R. Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 2001;86(4):1447-1463. doi: 10.1210/jcem.86.4.7407
3. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli J et al. Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy. The Journal of Clinical Endocrinology & Metabolism. 2006;91(8):2892-2899. doi: 10.1210/jc.2005-2838
4. Canavese G, Catturich A, Vecchio C, Tomei D, Estienne M, Moresco L et al. Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. European Journal of Surgical Oncology (EJSO). 1995;21(1):47-49. doi: 10.1016/s0748-7983(05)80067-8
5. Kang T, Shin J, Han B, Ko E, Kang S, Hahn S et al. Preoperative Ultrasound-Guided Tattooing Localization of Recurrences After Thyroidectomy: Safety and Effectiveness. Annals of Surgical Oncology. 2009;16(6):1655-1659. doi: 10.1245/s10434-009-0431-7
6. Soprani F, De Vito A, Bondi F, Magliulo G, Rene S, Cappi C et al. Preoperative charcoal suspension tattoo for the detection of differentiated thyroid cancer recurrence. Molecular and Clinical Oncology. 2019;. doi: 10.3892/mco.2019.1826